PRR
Prima Biomed
- Short interest
- 0.28%
- −0.06 pp 30d
- as of 10 Aug 2017
- Reported shorts
- 6.5M
- Shares on issue
- 2.343B
Prima Biomed (PRR) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for PRR (last checked 15 Oct 2026). The company's own filings are listed below.
Financial reports
The company's own filings, newest first
- Immutep Quarterly Activities Report and Appendix 4CQuarterly Report30 Apr 2026via asx_announcements
- Half Yearly Report and AccountsHalf Year Results25 Feb 2026via asx_announcements
- Immutep Quarterly Activities Report and Appendix 4CQuarterly Report29 Jan 2026via asx_announcements
- Immutep Quarterly Activities Report and Appendix 4CQuarterly Report29 Oct 2025via asx_announcements
- Annual Report filed on Form 20-FAnnual Report27 Oct 2025via asx_announcements
- Annual Report to shareholdersAnnual Report24 Oct 2025via asx_announcements
- Appendix 4E & 2025 Full Year Statutory AccountsAnnual Results29 Aug 2025via asx_announcements
- Immutep Quarterly Activities Report and Appendix 4CQuarterly Report30 Jul 2025via asx_announcements
- Immutep Quarterly Activities Report and Appendix 4CQuarterly Report29 Apr 2025via asx_announcements
- Half Yearly Report and AccountsHalf Year Results26 Feb 2025via asx_announcements
Showing 10 of 98 reports